Shorting HADV sounds interesting...
oh wait.. don't forget... 2x Patent Pending (FDA) pharmaceutical products
...Sounds like a winning idea... lol
Company Overview
Health Advance, Inc. is a publicly held Wyoming corporation, trading under ticker symbol OTC Pink: HADV, operating as a distributor of cost-effective conventional pharmaceutical products and GRAS (Generally Referred to as Safe) by the Food and Drug Administration (FDA) regulated medical foods that contain botanical extract blends in efforts to treat cancer, epilepsy, PTSD, and other severe illnesses, working in cooperation with international dietary supplement and pharmaceutical developers.
Cebidiofen
Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing cannabidiol and kava tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).
Polyoxyfen
Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing mitragyna speciose tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).